HLA antigens in Brazilian patients with paracoccidioidomycosis

L Z Goldani1, C M Monteiro, E A Donadi

  • 1Department of Internal Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Brazil.

Mycopathologia
|May 1, 1991
PubMed

Insights

This study found specific Human Leukocyte Antigen (HLA) types, particularly HLA-B40 and HLA-Cw1, are significantly more common in patients with paracoccidioidomycosis, suggesting a genetic link to the disease.

Area of Science:

  • Immunogenetics
  • Infectious Diseases
  • Human Genetics

Background:

  • Paracoccidioidomycosis is a serious fungal infection.
  • Genetic factors, particularly the Human Leukocyte Antigen (HLA) system, are suspected to influence susceptibility to infectious diseases.

Purpose of the Study:

  • To investigate the association between specific HLA alleles and haplotypes and the genetic susceptibility to paracoccidioidomycosis.
  • To identify potential genetic markers for paracoccidioidomycosis risk.

Main Methods:

  • Human Leukocyte Antigen (HLA) typing was performed on 80 patients with paracoccidioidomycosis for 43 specificities across HLA loci A, B, C, and DR.
  • Frequencies of HLA alleles and haplotypes in patients were compared to those in control subjects.

Main Results:

  • A significantly increased frequency of HLA-B40 (relative risk 29.2) and HLA-Cw1 (relative risk 8.8) was observed in patients.
  • HLA-A2, B7, and B21 frequencies were also elevated in patients.
  • The haplotypes HLA-B40-Cw1 and HLA-A2-B40 showed a positive correlation with the disease.
  • No significant alterations in DR antigen frequencies were found, and no protective HLA effects were identified.

Conclusions:

  • The Human Leukocyte Antigen (HLA) system plays a role in genetic susceptibility to paracoccidioidomycosis.
  • Specific HLA alleles and haplotypes are associated with an increased risk of developing paracoccidioidomycosis.
  • Ethnic variability is important in the HLA-paracoccidioidomycosis association.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...